When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
FATE - Fate Therapeutics: As Its Rally Fizzles We May Be Near The Bottom
Fate Therapeutics Inc.
2024-04-29 16:48:22 ET
Summary
Fate Therapeutics has a lot of potential in the cell therapy market, with multiple pipeline projects in development.
Their flagship allogeneic CAR T-cell project, FT819, has shown promising results in early reports, particularly in patients with B-cell lymphoma.
The company is also developing NK cell immunotherapies, with one program, FT522, showing positive results in patients with B-cell lymphoma. However, their cash burn rate remains high, which could be a risk.